文献速递临床微生物分子诊断

LIAISON PLEX 酵母血培养检测鉴定16种侵袭性真菌的性能评估

Performance of the LIAISON PLEX yeast blood culture assay for identifying 16 invasive fungal pathogens in blood cultures.
PubMed 文献 · J Clin Microbiol · 2025-06-02

多中心研究评估自动化多重 LIAISON PLEX 酵母血培养核酸检测对阳性血培养中14种念珠菌和2种隐球菌的检测性能,纳入69份前瞻标本、63份预选标本和829份模拟标本。结果显示目标真菌阳性检出率100%,阴性血培养阳性率0%,灵敏度和特异度表现优异。

要点

  • 该检测对16种目标真菌的阳性检出率为100%,阴性血培养阳性率为0%。
  • 前瞻联合预选标本的灵敏度/阳性符合率为100%,特异度/阴性符合率为97.6%–100.0%。
  • 检出限范围为7.77×10² CFU/mL(Candida famata)至2.83×10⁵ CFU/mL(Candida albicans)。

核心结论

  • LIAISON PLEX 酵母血培养检测对阳性血培养中真菌病原体的快速鉴定和区分具有出色的灵敏度和特异度。

研究设计与样本

  • 多中心研究评估自动化多重 LIAISON PLEX 酵母血培养核酸检测的分析和临床性能。
  • 样本包括69份前瞻性收集标本、63份预选样本和829份模拟标本。

主要发现

  • 检测目标真菌病原体阳性率为100%,阴性血培养阳性率为0%。
  • 13种测试瓶/基质类型对6种评估病原体均显示100%检出。
  • 检出限范围为7.77×10² CFU/mL(Candida famata)至2.83×10⁵ CFU/mL(Candida albicans)。
  • 16种目标菌种各测试5株,显示良好的包容性;40株细菌无交叉反应。
  • 前瞻联合预选标本灵敏度/阳性符合率为100%,特异度/阴性符合率为97.6%–100.0%;模拟标本阳性符合率100%,阴性符合率≥99.6%。

关键数值与推荐

  • 目标真菌阳性检出率100%,阴性血培养阳性率0%。
  • 前瞻联合预选标本灵敏度/阳性符合率100%,特异度/阴性符合率97.6%–100.0%。
  • 模拟标本阳性符合率100%,阴性符合率≥99.6%。
  • 重复性:实验室内100%,跨站点99.7%。

临床怎么用

  • 可用于阳性血培养中16种真菌病原体的快速鉴定,辅助早期优化抗真菌治疗。

局限性

  • 与37种非目标真菌中的2种(Candida [Yarrowia] deformans 和 Candida pseudohaemulonii)存在交叉反应,经计算机序列分析预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Fungi frequently cause potentially life-threatening bloodstream infections, particularly in immunocompromised and hospitalized individuals. Molecular methods can allow earlier pathogen identification for faster optimization of appropriate therapy. This multisite study evaluated the analytical and clinical performance of the automated multiplex LIAISON PLEX Yeast Blood Culture nucleic acid assay (Luminex Corporation, Northbrook, IL), which detects and identifies 14 Candida and 2 Cryptococcus pathogens from positive blood cultures. Samples included 69 prospectively collected specimens, 63 pre-selected samples, and 829 contrived specimens. The assay demonstrated 100% positivity in detecting target fungal pathogens and 0% positivity in negative blood cultures. All 13 tested bottle/matrix types gave 100% detection of six evaluated pathogens. Limits of detection ranged from 7.77 × 102 CFU/mL (Candida famata) to 2.83 × 105 CFU/mL (Candida albicans). The assay identified five strains tested for each of the 16 target species, indicating good inclusivity. No cross-reactivity occurred with 40 bacterial strains. Cross-reactivity with 2 of 37 off-target fungi (Candida [Yarrowia] deformans and Candida pseudohaemulonii) was predicted by in silico sequence analyses. Low concentrations of on-panel fungi were detectable alongside high concentrations of potential fungal and bacterial confounders. Reproducibility was 100% within-lab and 99.7% across sites. For combined prospective plus pre-selected specimens, sensitivity/positive percent agreement (PPA) was 100% for detected fungal pathogens, and specificity/negative percent agreement (NPA) was 97.6%‒100.0%. Common pathogens in prospective samples were Candida glabrata (36%) and C. albicans (25%). Contrived specimen PPA was 100%, and NPA was ≥99.6%. The LIAISON PLEX Yeast Blood Culture assay provides outstanding sensitivity and specificity for rapidly identifying and differentiating fungal pathogens in positive blood culture specimens. IMPORTANCE: Bloodstream fungal infections have serious risks of illness and death. Optimal treatment requires early pathogen identification so appropriate antifungal therapy can be immediately started. Blood culture is standard for confirming fungal infection but takes several days for results and may not provide detailed pathogen information. The LIAISON PLEX Yeast Blood Culture assay quickly analyzes fungus-positive blood cultures to identify 16 pathogenic fungi, including multiple Candida spp. that are common causes of bloodstream infection. This study demonstrated a high degree of test accuracy and reliability in rapidly identifying the infective pathogen in blood cultures from 132 patients with demonstrated culture-positive fungal infections. Assay performance was confirmed in 829 contrived samples, whereby samples were spiked with different fungal pathogens.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Emery CL, Dhiman N, Chow S-K, et al. Performance of the LIAISON PLEX yeast blood culture assay for identifying 16 invasive fungal pathogens in blood cultures. J Clin Microbiol. 2025. PMID: 40454839. doi:10.1128/jcm.00362-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。